The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Con­sumer and union groups call on FTC to ‘chal­lenge’ No­vo-Catal­ent deal

8 months ago
Deals
Pharma

House’s promi­nent Chi­na crit­ic Jim Mc­Gov­ern leads op­po­si­tion to Biose­cure Act: ‘I would pre­fer to go back to the draw­ing board’

8 months ago
China
Law

Evonik winds down Ger­man site, lays off 260 work­ers; Chiesi’s €400M fa­cil­i­ty

8 months ago

Mer­ck KGaA eyes more man­u­fac­tur­ing M&A as it faces head­winds in Chi­na

8 months ago
China

Cana­di­an CD­MO broad­ens CGT foot­print with new $145M fa­cil­i­ty 

8 months ago

Ex­clu­sive: Biotech tools com­pa­ny rais­es $75M for pro­tein man­u­fac­tur­ing tech 

9 months ago
Financing

Eli Lil­ly re­veals £279M in­vest­ment in the UK through new gov­ern­ment deal

9 months ago
Deals
Pharma

Catal­ent sells New Jer­sey plant to Bel­gian CD­MO, plans mov­ing HQ else­where

9 months ago
Deals

Eu­ro­pean drug­mak­ers look to reshore man­u­fac­tur­ing but warn of price hikes

9 months ago
Pharma

Sen. War­ren urges FTC to ‘care­ful­ly scru­ti­nize’ No­vo-Catal­ent deal over com­pe­ti­tion con­cerns

9 months ago
Deals
Pharma

Bax­ter plots re­cov­ery af­ter Hur­ri­cane He­lene, Mil­li­pore­Sig­ma’s €290M fa­cil­i­ty

9 months ago

Clients add pres­sure to CD­MOs to source raw ma­te­ri­als out­side of Chi­na, ex­ecs say

9 months ago
China

Zealand Phar­ma hit with sec­ond CRL for glucagon re­cep­tor ag­o­nist

9 months ago
Pharma
FDA+

Jim Wil­son se­cures $100M for glob­al ap­proach aimed at re­viv­ing gene ther­a­py field

9 months ago
Deals
Discovery

No­vo and Lil­ly out­line plans to mit­i­gate dis­rup­tions from US port strikes

9 months ago
Pharma

Pfiz­er lays off staff in Ire­land; Bax­ter clos­es NC fa­cil­i­ty due to hur­ri­cane dam­age

9 months ago

Gilead li­cens­es HIV shot to six gener­ic man­u­fac­tur­ers, but falls short of ac­cess sought by ad­vo­cates

9 months ago
Pharma

J&J bud­gets over $2B for new North Car­oli­na bi­o­log­ics fa­cil­i­ty

9 months ago
Pharma

Lil­ly in­vests $4.5B in new In­di­ana site to bring clin­i­cal man­u­fac­tur­ing in-house

9 months ago
R&D
Pharma

Met­sera part­ners with Am­neal to man­u­fac­ture obe­si­ty drugs, and Clive Mean­well hands over CEO role

9 months ago
Startups
Deals

No­vo Nordisk to de­crease some in­sulin pen man­u­fac­tur­ing, tran­si­tion sup­ply

9 months ago
Pharma

Tra­vere halts Phase 3 in­her­it­ed dis­ease tri­al due to man­u­fac­tur­ing scale-up is­sue

9 months ago
R&D

AGC Bi­o­log­ics to lay off 95 work­ers; Ver­tex taps Lon­za to man­u­fac­ture Cas­gevy

9 months ago

CSL Se­qirus inks fifth con­tract with BAR­DA, mak­ing the part­ner­ship now worth $1.14B

9 months ago
Deals
First page Previous page 78910111213 Next page Last page
A service from the Financial Times